Detalhe da pesquisa
1.
Research autopsy programmes in oncology: shared experience from 14 centres across the world.
J Pathol
; 263(2): 150-165, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551513
2.
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
J Immunol
; 211(2): 219-228, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204246
3.
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer.
Lancet Oncol
; 25(4): e139-e151, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547898
4.
BIRC5 expression by race, age and clinical factors in breast cancer patients.
Breast Cancer Res
; 26(1): 50, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38515208
5.
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Cancer
; 130(5): 750-769, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916800
6.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 384(16): 1529-1541, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882206
7.
Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer.
Nature
; 556(7699): 135, 2018 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29620732
8.
Asparagine bioavailability governs metastasis in a model of breast cancer.
Nature
; 554(7692): 378-381, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29414946
9.
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
JAMA
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683596
10.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Lancet Oncol
; 24(3): 273-285, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858723
11.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med
; 382(7): 597-609, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825569
12.
Burden of lymphedema in long-term breast cancer survivors by race and age.
Cancer
; 128(23): 4119-4128, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223240
13.
Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
Breast Cancer Res Treat
; 196(1): 153-162, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008651
14.
Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer.
Cancer
; 127(6): 922-930, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284988
15.
Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
Cancer
; 127(6): 957-967, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216355
16.
Race and smoking status associated with paclitaxel drug response in patient-derived lymphoblastoid cell lines.
Pharmacogenet Genomics
; 31(2): 48-52, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941389
17.
Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance).
Ann Surg Oncol
; 28(11): 5960-5971, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821344
18.
A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic triple-negative breast cancer.
Future Oncol
; 17(30): 3911-3924, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467774
19.
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
Future Oncol
; 17(34): 4665-4676, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636255
20.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152285